Y. Muto

Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis

Takashi Yoshida, Y. Muto, H Moriwaki et al. · Gastroenterologia Japonica · 1989 · 134 citations

Nutrition, Hepatology, Long-term Oral Supplementation +10

High Levels of Serum Interleukin‐10 and Tumor Necrosis Factor–α Are Associated with Fatality in Fulminant Hepatitis

Masahito Nagaki, Hiroko Iwai, Hiroo Ohnishi et al. · The Journal of Infectious Diseases · 2000 · 100 citations

Ulinastatin, a protease inhibitor, attenuates hepatic ischemia/reperfusion injury by downregulating TNF-α in the liver

Tsukasa Aihara, Mitsuya Shiraishi, Shungo Hiroyasu et al. · Transplantation Proceedings · 1998 · 27 citations

Inflammation, Hepatology, Protease Inhibitor +13

Significance of tumor necrosis factor (TNF) and interleukin-1 (IL-1) in the pathogenesis of fulminant hepatitis: Possible involvement of serine protease in TNF-mediated liver injury

Masahito Nagaki, Y. Muto, Hiroo Ohnishi et al. · Gastroenterologia Japonica · 1991 · 20 citations

Inflammation, Tumor Necrosis Factor, Liver Fibrosis +15

Peptic ulcer recurrence during maintenance therapy with H 2 -receptor antagonist following first-line therapy with proton pump inhibitor

Eizō Kaneko, Yoshio Hoshihara, Nobuhiro Sakaki et al. · Journal of Gastroenterology · 2000 · 19 citations

Gastrointestinal Pharmacology, Pharmacology, Gastroenterology +6